We serve Chemical Name:methyl 6-(2-bromoanilino)-5-oxo-2,3-dihydro-1H-indolizine-8-carboxylate CAS:612065-15-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 6-(2-bromoanilino)-5-oxo-2,3-dihydro-1H-indolizine-8-carboxylate
CAS.NO:612065-15-3
Synonyms:methyl 5-oxo-6-(2-bromophenylamino)-1,2,3,5-tetrahydroindolizine-8-carboxylate;6-(2-bromo-phenylamino)-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid methyl ester;METHYL 6-(2-BROMOPHENYLAMINO)-5-OXO-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE
Molecular Formula:C16H15BrN2O3
Molecular Weight:363.20600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:60.33000
Exact Mass:362.02700
LogP:3.16020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like methyl 5-oxo-6-(2-bromophenylamino)-1,2,3,5-tetrahydroindolizine-8-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,METHYL 6-(2-BROMOPHENYLAMINO)-5-OXO-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,METHYL 6-(2-BROMOPHENYLAMINO)-5-OXO-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE Use and application,methyl 5-oxo-6-(2-bromophenylamino)-1,2,3,5-tetrahydroindolizine-8-carboxylate technical grade,usp/ep/jp grade.
Related News: The relationship between a CDMO and the company also depends on influencing aspects such as transparent communication, involvement at every step, and support while dealing with challenges. 2a,2b,3,4,5,6,6a,6b-octahydro-spiro[cyclopropa[cd]azulene-1,3′-diazirin]-2-one manufacturers Ireland is globally recognised as a hub for the Life Sciences sector and this news is a real vote of confidence in us and our capacity.” Benzamide,N-[(3R,4R)-3-(2,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)tetrahydro-2H-pyran-4-yl]-4-[(2-methyl-4-quinolinyl)methoxy]-, rel- suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2-(4-Chloro-phenyl)-1-(5-ethyl-2,4-dihydroxy-phenyl)-ethanone vendor & factory.
